Wen-Ling Kuo

Dr. Wen-Ling Kuo

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2020 in Clinical Breast Cancer
Verified
Journal Article
Closed access
WKWen-Ling Kuo
Wen-Ling Kuo
JHJung-Ju Huang
Jung-Ju Huang
YHYi-Ting Huang
Yi-Ting Huang
LCLi-Fen Chueh
Li-Fen Chueh
JLJui-Ting Lee
Jui-Ting Lee
SCShin-Cheh Chen
Shin-Cheh Chen

28 October 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
WSWen-Chi Shen
Wen-Chi Shen
SCShin-Cheh Chen
Shin-Cheh Chen
JWJerry Cheng-Hsu Wang
Jerry Cheng-Hsu Wang
CHChao-Ming Hung
Chao-Ming Hung
MPMeng-Ting Peng
Meng-Ting Peng
KRKun-Ming Rau
Kun-Ming Rau
This study aimed to evaluate the effect of Astragalus polysaccharides (PG2) on reducing chemotherapy-induced fatigue (CIF) and toxicity, thereby encouraging compliance to chemotherapy. This was a randomized, placebo-controlled, phase 2 study. Patients with stage II/III early breast cancer planning to undergo adjuvant anthracycline-based chemotherapy were randomly assigned to receive PG2 500 mg or placebo on days 1, 3, and 8 every 21 days. The fatigue global score (FGS) was assessed using the brief fatigue inventory (BFI)-Taiwan. The Breast Cancer-Specific Module of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaires-Core30 evaluated the health-related quality of life during the first four cycles of adjuvant chemotherapy. Overall, 66 eligible patients were equally randomized into the PG2 and placebo groups between March 01, 2018, and March 09, 2021. The mean change in the FGS and fatigue intensity did not significantly differ between both groups. However, the FGS and fatigue intensity were less aggravated in the first four cycles in the premenopausal-PG2 group than in the placebo group. Our study concluded PG2 combined with adjuvant chemotherapy can reduce CIF, insomnia, the negative effect on future perspectives, and improve global health status, especially for premenopausal patients with breast cancer. Trial registration number: NCT03314805 registered on 19/10/2017.

1 January 2025 in Journal of Breast Cancer
Verified
Journal Article
Open access
PDF file
JRJai Min Ryu
Jai Min Ryu
CMChi Wei Mok
Chi Wei Mok
ATAntonio Toesca
Antonio Toesca
HLHung-Wen Lai
Hung-Wen Lai
WKWen-Ling Kuo
Wen-Ling Kuo
HPHyung Seok Park
Hyung Seok Park
Ryu JM, et al. J Breast Cancer. 2025 May;28:e18. https://doi.org/10.4048/jbc.2025.0030

21 January 2025 in European Journal of Surgical Oncology
Verified
Journal Article
Closed access
WKWen-Ling Kuo
Wen-Ling Kuo
JHJung-Ju Huang
Jung-Ju Huang
CCChia-Huei Chu
Chia-Huei Chu
SCShu-Chen Chang
Shu-Chen Chang
YLYuJr Lin
YuJr Lin
SCShin-Cheh Chen
Shin-Cheh Chen

12 March 2025 in International Journal of Surgery
Verified
Journal Article
Open access
SSShiuan Shyu
Shiuan Shyu
TCTommy Nai-Jen Chang
Tommy Nai-Jen Chang
JLJohnnyChuieng-Yi MD Lu
JohnnyChuieng-Yi MD Lu
CCChia-Fang Chen
Chia-Fang Chen
DCDavid Chon Fok Cheong
David Chon Fok Cheong
JHJung-Ju Huang
Jung-Ju Huang
Objective: Persistent postoperative sensory loss significantly limits breast reconstruction following mastectomy. In addition, the absence of sensation profoundly impacts patients’ physical well-being and overall quality of life. New surgical techniques involving nerve autograft intercostal nerve elongation have been introduced to neurotize reconstructed breasts. However, patient quality of life after neurotization has not been well evaluated. This study aimed to investigate improvements in patient quality of life in association with breast neurotization. Methods: A prospective cohort study of 132 patients treated at Chang Gung Memorial Hospital between January 2018 and December 2022 was conducted. Two groups of patients who underwent nipple-sparing mastectomy (NSM) and breast reconstruction were compared: those with (n = 67) and without (n = 65) breast neurotization. Patient-reported outcomes were assessed via the BREAST-Q reconstruction module questionnaire and an additional questionnaire measuring sensation, nipple satisfaction, and breast symptoms. Objective measurements were conducted via the Semmes–Weinstein monofilaments test. Results: With respect to patient-reported outcomes, the innervated group had significantly higher scores for nipple sensation and on the BREAST-Q domains of psychosocial well-being (71.6 ± 18.1 vs. 62.8 ± 18.6, P = 0.006), sexual well-being (56.9 ± 22.1 vs. 47.3 ± 20.7, P = 0.015), satisfaction with the medical team, as well as less frequent post-operative breast symptoms. In the subgroup analysis, the innervated group demonstrated higher scores in both autologous flap and implant-based reconstruction. Linear regression revealed a statistically significant relationship between objectively measured monofilament value and subjectively examined patient-reported outcomes: nipple sensation, breast sensation, and BREAST-Q score for the psychosocial well-being domain (coefficient: −4.922, P = 0.033). Conclusion: Breast reconstruction with autologous nerve graft neurotization yields improved sensory outcomes and has a statistically significant positive impact on the quality of life of breast reconstruction patients.

30 May 2021 in Applied Sciences
Verified
Journal Article
Open access
PDF file
Jenhui ChenJenhui Chen
Jenhui Chen
Obinna AgbodikeObinna Agbodike
Obinna Agbodike
WKWen-Ling Kuo
Wen-Ling Kuo
Lei WangLei Wang
Lei Wang
Chiao-Hua HuangChiao-Hua Huang
Chiao-Hua Huang
BCBing-Hong Chen
Bing-Hong Chen
The increasing number of female breast cancer (FBC) incidences in the East predominated by Chinese language speakers has generated concerns over women’s medicare. To minimize the mortality rate associated with FBC in the region, governments and health experts are jointly encouraging women to undergo mammography screening at the earliest suspicion of FBC symptoms. However, studies show that a huge number of women affected by FBC tend to delay medical consultation at its early stage as a result of factors such as complacency due to unawareness of FBC symptoms, procrastination due to lifestyle, and the feeling of embarrassment in discussing private matters especially with medical personnel of the opposite gender. To address these issues, we propose a symptomatic assessment chatbot (SAC) based on artificial intelligence (AI) designed to prescreen women for FBC symptoms via a textual question-and-answer (Q&A) approach. The purpose of our chatbot is to assist women in engaging in communication regarding FBC symptoms, so as to subsequently initiate formal medical consultations for early FBC diagnosis and treatment. We implemented the SAC systematically with some of the latest natural language processing (NLP) techniques suitable for Chinese word segmentation (CWS) and trained the model with real-world FBC Q&A data obtained from a major hospital in Taiwan. The results from our experiments showed that the SAC achieved very high accuracy in FBC assessment scoring in comparison to FBC patients’ screening benchmark scores obtained from doctors.